Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey

References

• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
   PubMed Web of Science ®Google Scholar
• Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;77:162–72.
   Google Scholar
• Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler. 2009;10:324–31.
   PubMed Web of Science ®Google Scholar
• Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Balendra R, Al Khleifat A, Fang T, Al-Chalabi A. A standard operating procedure for King’s ALS clinical staging. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:159–64.
   PubMed Web of Science ®Google Scholar
• Corcia P, Beltran S, Lautrette G, Bakkouche S, Couratier P. Staging amyotrophic lateral sclerosis: a new focus on progression. Rev Neurol. 2019;175:277–82.
   PubMedGoogle Scholar
• Chiò A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:38–44.
   PubMed Web of Science ®Google Scholar
• Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265–7.
   PubMed Web of Science ®Google Scholar
• Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D, et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler. 2006;7:173–82.
   PubMed Web of Science ®Google Scholar
• Takeda T, Kitagawa K, Arai K. Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology. 2020;40:40–56.
   PubMed Web of Science ®Google Scholar
• Witzel S, Wagner M, Zhao C, Kandler K, Graf E, Berutti R, et al. Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum. Neurobiol Aging. 2022;119:117–26.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
   PubMed Web of Science ®Google Scholar
• Rosenbohm A, Peter RS, Erhardt S, Lulé D, Rothenbacher D, Ludolph AC, et al. Epidemiology of amyotrophic lateral sclerosis in Southern Germany. J Neurol. 2017;264:749–57.
   PubMed Web of Science ®Google Scholar
• Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423–33.
   PubMed Web of Science ®Google Scholar
• Meng L, Bian A, Jordan S, Wolff A, Shefner JM, Andrews J. Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:134–42.
   PubMed Web of Science ®Google Scholar
• Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci. 2020;417:117054.
   PubMed Web of Science ®Google Scholar
• Vacchiano V, Di Stasi V, Rizzo G, Giannoccaro MP, Donadio V, Bartolomei I, et al. Prognostic value of EMG genioglossus involvement in amyotrophic lateral sclerosis. Clin Neurophysiol. 2021;132:2416–21.
   PubMed Web of Science ®Google Scholar
• Spataro R, Ciriacono M, Manno C, La Bella V. The eye-tracking computer device for communication in amyotrophic lateral sclerosis. Acta Neurol Scand. 2014;130:40–5.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A,. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:163–7.
   PubMed Web of Science ®Google Scholar
• Makkonen T, Ruottinen H, Puhto R, Helminen M, Palmio J. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms. Int J Lang Commun Disord. 2018;53:385–92.
   PubMed Web of Science ®Google Scholar
• Fileccia E, De Pasqua S, Rizzo G, Di Stasi V, Vacchiano V, Avoni P, et al. Denervation findings on EMG in amyotrophic lateral sclerosis and correlation with prognostic milestones: Data from a retrospective study. Clin Neurophysiol. 2020;131:2017–22.
   PubMed Web of Science ®Google Scholar
• Talman P, Duong T, Vucic S, Mathers S, Venkatesh S, Henderson R, et al. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian national motor neuron disease observational cohort. BMJ Open. 2016;6:e012054.
   PubMed Web of Science ®Google Scholar
• Mariani L, Ruoppolo G, Cilfone A, Cocchi C, Preziosi Standoli J, Longo L, et al. Progression of oropharyngeal dysphagia in amyotrophic lateral sclerosis: a retrospective cohort study. Dysphagia 2022;37:868–78.
   PubMedGoogle Scholar
• Vergonjeanne M, Fayemendy P, Marin B, Penoty M, Lautrette G, Sourisseau H, et al. Predictive factors for gastrostomy at time of diagnosis and impact on survival in patients with amyotrophic lateral sclerosis. Clin Nutr. 2020;39:3112–8.
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life-tables. JR StatSoc: Series B (Methodol) 1972;34:187–202.
   Web of Science ®Google Scholar
• Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand. Curr Med Res Opin. 2008;24:3063–72.
   PubMed Web of Science ®Google Scholar
• Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open. 2016;66:e010352.
   PubMed Web of Science ®Google Scholar
• Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371–80.
   PubMed Web of Science ®Google Scholar
• DeTora LM, Lane T, Sykes A, DiBiasi F, Toroser D, Citrome L. Good publication practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2023;176:eL220490.
   PubMedGoogle Scholar
• Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, et al. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:453–6.
   PubMed Web of Science ®Google Scholar
• Lu CH, Petzold A, Topping J, Allen K, Macdonald-Wallis C, Clarke J, et al. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J Neurol Neurosurg Psychiatry. 2015;86:565–73.
   PubMed Web of Science ®Google Scholar
• Rong P, Yunusova Y, Eshghi M, Rowe HP, Green JR. A speech measure for early stratification of fast and slow progressors of bulbar amyotrophic lateral sclerosis: lip movement jitter. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:34–41.
   PubMed Web of Science ®Google Scholar
• National institute for Health and Care Excellence. Motor neurone disease: assessment and management [Internet]. 2023 [cited 2020 Jan 15]. Available from: https://www.nice.org.uk/guidance/ng42
   Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• ResMed. Respiratory assist device (RAD) coverage guidelines [Internet]. 2019 [cited 2020 Jan 15]. Available from: https://www.resmed.com/us/dam/documents/articles/1010293_RAD_Guidelines.pdf
   Google Scholar
• Eurostat Statistical Office of the European Union. Body mass index (BMI) by sex, age and educational attainment level [Internet]. 2022 [cited 2023 Jun 13]. Available from: https://ec.europa.eu/eurostat/databrowser/view/HLTH_EHIS_BM1E__custom_1162105/bookmark/table?lang=en&bookmarkId=6f21bd9e-cbe6-4467-9821-2050435af363
   Google Scholar
• Centers for Disease Control and Prevention. Adult Obesity Facts [Internet]. 2022 [cited 2023 Jun 13]. Available from: https://www.cdc.gov/obesity/data/adult.html
   Google Scholar
• Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90:666–73.
   PubMed Web of Science ®Google Scholar
• Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, et al. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. 2017;32:901–8.
   PubMed Web of Science ®Google Scholar
• O'Reilly ÉJ, Wang M, Adami H-O, Alonso A, Bernstein L, van den Brandt P, et al. Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:396–06.
   PubMed Web of Science ®Google Scholar
• Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology 2013;80:829–38.
   PubMed Web of Science ®Google Scholar
• Mariosa D, Beard JD, Umbach DM, Bellocco R, Keller J, Peters TL, et al. Body mass index and amyotrophic lateral sclerosis: a study of US Military Veterans. Am J Epidemiol. 2017;85:362–71.
   Google Scholar
• Goutman SA, Boss J, Iyer G, Habra H, Savelieff MG, Karnovsky A, et al. Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle Nerve. 2023;67:208–16.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Siokas V, Sokratous M, Tsouris Z, Aloizou AM, Florou D, et al. Body mass index and survival from amyotrophic lateral sclerosis: a meta-analysis. Neurol Clin Pract. 2018;8:437–44.
   PubMedGoogle Scholar
• Office for National Statistics. Ethnicity Facts and Figures: Population of England and Wales [Internet]. 2022 [cited 2023 Nov 6]. Available from: https://www.ethnicity-facts-figures.service.gov.uk/uk-population-by-ethnicity/national-and-regional-populations/population-of-england-and-wales/latest#by-ethnicity
   Google Scholar
• United States Census Bureau. Racial and Ethnic Diversity in the United States: 2010 Census and 2020 Census [Internet]. 2022 [cited 2023 Nov 6]. Available from: https://www.census.gov/library/visualizations/interactive/racial-and-ethnic-diversity-in-the-united-states-2010-and-2020-census.html
   Google Scholar
• Eurostat Statistical Office of the European Union. Population Structure and Ageing [Internet]. 2023 [cited 2023 Nov 6]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing&stable=1#Median_age_is_highest_in_Italy_and_lowest_in_Cyprus
   Google Scholar
• United States Census Bureau. America Is Getting Older [Internet]. 2023 [cited 2023 Nov 6]. Available from: https://www.census.gov/newsroom/press-releases/2023/population-estimates-characteristics.html
   Google Scholar
• Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363–80.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the. Neurology 2009;73:1227–33.
   PubMed Web of Science ®Google Scholar